{
    "SPADE_N_14055": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14055",
            "Peptide Name": "PMAP-37(F34-R) (PMAP-37 F34R, synthetic AMPs, UCLL1; Derivative: Chol-37(F34-R))",
            "Source": "Amino acid substitution, cathelicidin analog, animal-derived, natural derivative",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSERFQS",
            "Sequence Length": 37,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 4373.98,
            "PI": 10.8,
            "Hydrophobicity": -0.92,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Zhou J, Chen L, Liu Y, Shen T, Zhang C, Liu Z, Feng X, Wang C. 2019",
                    "Reference": "J Pept Sci. 2019 Dec;25(12):e3220. doi: 10.1002/psc.3220.PubMed",
                    "Title": "Antimicrobial peptide PMAP-37 analogs: Increasing the positive charge to enhance the antibacterial activity of PMAP-37."
                }
            ],
            "Frequent Amino Acids": "RLG",
            "Absent Amino Acids": "ACHMNOPTUVWY",
            "Basic Residues": 10,
            "Acidic Residues": 6,
            "Hydrophobic Residues": 11,
            "Polar Residues": 16,
            "Positive Residues": 10,
            "Negative Residues": 6,
            "Net Charge": 4,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (97.3%) toparent \tPMAP-37Activity: Active against Gram+ S. aureusATCC25923 (MIC 0.025 ug/ml), S. epidermidis LY8 (MIC 25 ug/ml), L. monocytogenes CICC21533 (MIC 31.25 ug/ml), B. subtilis CICC24434 (MIC 0.78 ug/ml), Gram- S. choleraesuis C78-1 (MIC 0.78 ug/ml), S. typhimurium SL1344 (MIC 0.78 ug/ml), P. avium C48-3 (MIC 1.56 ug/ml), and E. coli CICC10004 (MIC 6.25 ug/ml).Antimicrobial robustness: pH-sensitive especially above pH 12; activity reduced with boiling time to 120 min.Recombinant production:yeast:Pichia pastoris: this variant has been expressed and further characterized.Animal model:mouse: more animal survived with the peptide treatment for 3 days.Peptide conjugate: coupling cholesterol at the N-terminus of the peptide increased peptide activity, stability and in vivo efficacy (Chen et al., 2020).",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_22046",
                    "Similarity": 1.0,
                    "Sequence": "GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSERFQS"
                },
                {
                    "SPADE_ID": "SPADE_UN_24334",
                    "Similarity": 1.0,
                    "Sequence": "GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSERFQS"
                },
                {
                    "SPADE_ID": "SPADE_N_02562",
                    "Similarity": 0.972972972972973,
                    "Sequence": "GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSEFFQS"
                }
            ]
        }
    }
}